Role of Telemedicine in Congenital Heart Disease Care Models in Low‐ and Middle‐Income Countries: A Scientific Statement From the American Heart Association
Abstract
Telemedicine is increasingly recognized as a transformative strategy to address critical challenges in low- and middle-income countries, which comprise 63% of all nations, 84% of the global population, and 90% of children <15 years of age. These regions experience multiple barriers, including geographic remoteness, economic constraints, limited healthcare infrastructure, and a shortage of trained healthcare professionals. Congenital heart disease, a highly specialized field often centralized in urban centers, is particularly affected, leaving many children without timely or equitable access to life-saving care. In this context, telecardiology has emerged as a valuable tool across the congenital heart disease care continuum, supporting prehospital assessment, inpatient management, postdischarge follow-up, and multidisciplinary collaboration. Beyond video consultations, telemedicine enables secure transmission of electrocardiograms, echocardiograms, advanced imaging, and digital auscultation data. Artificial intelligence-based tools further enhance education, diagnostic support, and quality assurance in image acquisition. Together, these capabilities reduce unnecessary travel, expedite specialist input, strengthen local decision-making, and contribute to improved outcomes. Telemedicine also facilitates collaboration among pediatric cardiologists, neonatologists, intensivists, imaging specialists, and nurses, fostering more integrated and resilient care networks that link peripheral facilities with tertiary centers. By optimizing limited resources and expanding specialist reach, telemedicine holds significant promise for improving access, equity, and outcomes in congenital heart disease care across low- and middle-income countries. Continued investment, strategic planning, and collaborative capacity-building will be essential to ensure its sustainable and effective implementation worldwide.
Related
- The European Anthropological Association (EAA) position statement on anthropometry: education, competence, and scientific authority
- Role of Physical Activity in Obesity Treatment and Cardiometabolic Health: A Scientific Statement From the American Heart Association
- Cost-Effectiveness of Telemedicine-Based Screening Programs for Retinopathy of Prematurity in Low- and Middle-Income Countries
- Thromboprophylaxis in congenital and acquired heart disease across the lifespan. A French consensus position statement: Part 2 – from adolescence to adulthood
- Telemedicine Patient Satisfaction Across Nine Countries: A Cross-Sectional Comparative Study.
BibTeX
@article{mattos2026role,
title = {{Role of Telemedicine in Congenital Heart Disease Care Models in Low‐ and Middle‐Income Countries: A Scientific Statement From the American Heart Association}},
author = {Sandra S. Mattos and Dominique Vervoort and Shazia Moshin and Gary Sholler and Yashendra Sethi and Sunita Maheshwari and Kun Sun and Derrick A. Bennett and Liesl Joanna Zühlke and Sandra Staveski and the American Heart Association Council on Lifelong Congenital Heart Disease and Heart Health in the Young, Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee; Council on Clinical Cardiology; and the Council on Cardiovascular and Stroke Nursing},
journal = {Journal of the American Heart Association},
year = {2026},
month = oct,
doi = {10.1161/jaha.126.054084},
url = {https://www.ahajournals.org/doi/10.1161/JAHA.126.054084},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Role of Telemedicine in Congenital Heart Disease Care Models in Low‐ and Middle‐Income Countries: A Scientific Statement From the American Heart Association
AU - Sandra S. Mattos
AU - Dominique Vervoort
AU - Shazia Moshin
AU - Gary Sholler
AU - Yashendra Sethi
AU - Sunita Maheshwari
AU - Kun Sun
AU - Derrick A. Bennett
AU - Liesl Joanna Zühlke
AU - Sandra Staveski
AU - the American Heart Association Council on Lifelong Congenital Heart Disease and Heart Health in the Young, Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee; Council on Clinical Cardiology; and the Council on Cardiovascular and Stroke Nursing
PY - 2026
DA - 2026/10/05
JO - Journal of the American Heart Association
DO - 10.1161/jaha.126.054084
UR - https://www.ahajournals.org/doi/10.1161/JAHA.126.054084
AB - Telemedicine is increasingly recognized as a transformative strategy to address critical challenges in low- and middle-income countries, which comprise 63% of all nations, 84% of the global population, and 90% of children <15 years of age. These regions experience multiple barriers, including geographic remoteness, economic constraints, limited healthcare infrastructure, and a shortage of trained healthcare professionals. Congenital heart disease, a highly specialized field often centralized in urban centers, is particularly affected, leaving many children without timely or equitable access to life-saving care. In this context, telecardiology has emerged as a valuable tool across the congenital heart disease care continuum, supporting prehospital assessment, inpatient management, postdischarge follow-up, and multidisciplinary collaboration. Beyond video consultations, telemedicine enables secure transmission of electrocardiograms, echocardiograms, advanced imaging, and digital auscultation data. Artificial intelligence-based tools further enhance education, diagnostic support, and quality assurance in image acquisition. Together, these capabilities reduce unnecessary travel, expedite specialist input, strengthen local decision-making, and contribute to improved outcomes. Telemedicine also facilitates collaboration among pediatric cardiologists, neonatologists, intensivists, imaging specialists, and nurses, fostering more integrated and resilient care networks that link peripheral facilities with tertiary centers. By optimizing limited resources and expanding specialist reach, telemedicine holds significant promise for improving access, equity, and outcomes in congenital heart disease care across low- and middle-income countries. Continued investment, strategic planning, and collaborative capacity-building will be essential to ensure its sustainable and effective implementation worldwide.
SN - 2047-9980
ER -